Supreme Court’s Decision on Purdue Case Likely to Have Narrow Impact, Experts Suggest
Washington — The recent Supreme Nourt ruling on Purdue Pharma’s bankruptcy settlement has sparked widespread concern, hinting at potentially far-reaching implications for the opioid crisis and corporate accountability. However, legal experts suggest that the impacts of this decision may be more limited than initially feared. Purdue Pharma, the maker of OxyContin, reached a bankruptcy settlement that partially shields the Sackler family, who owns the company, from future opioid litigation. This provision has been controversial, as the Sackler family has been widely criticized for their role in the opioid epidemic, which has claimed over 500,000 lives … Read more